Growth Metrics

Bio-Techne (TECH) Cash & Current Investments (2016 - 2026)

Bio-Techne has reported Cash & Current Investments over the past 17 years, most recently at $172.9 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 4.37% year-over-year to $172.9 million; the TTM value through Dec 2025 reached $172.9 million, down 4.37%, while the annual FY2025 figure was $165.0 million, 7.96% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $172.9 million at Bio-Techne, up from $145.0 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $279.0 million in Q4 2021 and troughed at $135.7 million in Q4 2023.
  • A 5-year average of $189.8 million and a median of $182.2 million in 2022 define the central range for Cash & Current Investments.
  • Biggest five-year swings in Cash & Current Investments: crashed 32.0% in 2023 and later soared 33.26% in 2024.
  • Year by year, Cash & Current Investments stood at $279.0 million in 2021, then decreased by 29.47% to $196.8 million in 2022, then crashed by 31.06% to $135.7 million in 2023, then soared by 33.26% to $180.8 million in 2024, then fell by 4.37% to $172.9 million in 2025.
  • Business Quant data shows Cash & Current Investments for TECH at $172.9 million in Q4 2025, $145.0 million in Q3 2025, and $165.0 million in Q2 2025.